Artigo de periodico

Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer (2020)

• Authors:
  • Parra, Edwin Roger
  • Jiang, Mei
  • Machado-rugolo, Juliana
  • Yaegashi, Lygia Bertalha
  • Prieto, Tabatha
  • Farhat, Cecília
  • Sá, Vanessa Karen de
  • Nagai, Maria Aparecida
  • Lima, Vladmir Cláudio Cordeiro de
  • Takagaki, Teresa Yae
  • Terra, Ricardo Mingarini
  • Fabro, Alexandre Todorovic
  • Capelozzi, Vera Luiza
• USP affiliated authors: NAGAI, MARIA APARECIDA - FM ; TAKAGAKI, TERESA YAE - FM ; TERRA, RICARDO MINGARINI - FM ; FABRO, ALEXANDRE TODOROVIC - FMRP ; CAPELOZZI, VERA LUIZA - FM ; RUGOLO, JULIANA MACHADO - FSP ; YAEGASHI, LYGIA BERTALHA - FM
• Unidades: FM; FMRP; FSP
• DOI: 10.5858/arpa.2019-0419-OA
• Subjects: ANTÍGENOS; CARCINOMA; PULMÃO; NEOPLASIAS PULMONARES; LINFÓCITOS; IMUNOLOGIA; TAXA DE SOBREVIVÊNCIA
• Agências de fomento:
  • Financiado pelo Texas Lung Cancer Specialized Programs of Research Excellence
  • Financiado pela FAPESP
• Language: Inglês
• Imprenta:
  • Publisher place: Northfield
  • Date published: 2020
• Source:
  • Título: Archives of Pathology & Laboratory Medicine
  • ISSN: 0003-9985
  • Volume/Número/Paginação/Ano: v. 144, n. 10, p. 1234-1244, 2020


Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).

Status:

Artigo publicado em periódico de acesso aberto (Gold Open Access)

Versão do Documento:

Versão publicada (Published version)

Acessar versão aberta:

• PDF de acesso aberto

Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.

---

Download do texto completo

Tipo	Nome	Link
	003024059.pdf

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  PARRA, Edwin Roger et al. Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer. Archives of Pathology & Laboratory Medicine, v. 144, n. 10, p. 1234-1244, 2020Tradução . . Disponível em: https://doi.org/10.5858/arpa.2019-0419-OA. Acesso em: 01 abr. 2026.

• APA

  Parra, E. R., Jiang, M., Machado-rugolo, J., Yaegashi, L. B., Prieto, T., Farhat, C., et al. (2020). Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer. Archives of Pathology & Laboratory Medicine, 144( 10), 1234-1244. doi:10.5858/arpa.2019-0419-OA

• NLM

  Parra ER, Jiang M, Machado-rugolo J, Yaegashi LB, Prieto T, Farhat C, Sá VK de, Nagai MA, Lima VCC de, Takagaki TY, Terra RM, Fabro AT, Capelozzi VL. Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer [Internet]. Archives of Pathology & Laboratory Medicine. 2020 ; 144( 10): 1234-1244.[citado 2026 abr. 01 ] Available from: https://doi.org/10.5858/arpa.2019-0419-OA

• Vancouver

  Parra ER, Jiang M, Machado-rugolo J, Yaegashi LB, Prieto T, Farhat C, Sá VK de, Nagai MA, Lima VCC de, Takagaki TY, Terra RM, Fabro AT, Capelozzi VL. Variants in epithelial-mesenchymal transition and immune checkpoint genes are associated with immune cell profiles and predict survival in non–small cell lung cancer [Internet]. Archives of Pathology & Laboratory Medicine. 2020 ; 144( 10): 1234-1244.[citado 2026 abr. 01 ] Available from: https://doi.org/10.5858/arpa.2019-0419-OA

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Relevance of PD-L1 non-coding polymorphisms on the prognosis of a genetically admixed NSCLC cohort
• Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer
• Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor
• Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients
• Cyclic ACTH-secreting thymic carcinoid: a case report and review of the literature
• PI4K2A. [Editorial]: a novel potential therapeutic target for lung cancer
• Downregulation of DNAJC12 expression predicts worse survival for ER-positive breast câncer patients
• Next-generation sequencing of non-small cell lung cancer using a customized, targeted sequencing panel: focus on epithelial-mesenchymal transition
• Mutation profile and protein expression for predictive testing in lung adenocarcinoma: a study of 200 patients from Brazil
• Interobserver agreement of usual interstitial pneumonia diagnosis correlated with patient outcome